Florence, Italy, December 11, 2024 – Retina Futura is delighted to announce the winners of its prestigious awards, recognizing groundbreaking innovations and advancements in the treatment of retinal diseases. This year’s awards honor pioneering contributions that are shaping the future of ophthalmology and improving patient outcomes worldwide.
This year, ABBV-RGX-314: A Promising Gene Therapy for Retinal Diseases had a clear sweep across all three categories:
Newcomer of the Year
ABBV-RGX-314 for Diabetic Retinopathy and wet AMD including Fellow Eye
Most Innovative Science
ABBV-RGX-314 for Diabetic Retinopathy
Most Clinically Impactful
ABBV-RGX-314 for wet AMD including Fellow Eye
This investigational gene therapy developed for retinal conditions such as wet AMD and diabetic retinopathy, offers a novel approach to treatment. Utilizing a targeted delivery mechanism, this therapy aims to reduce the need for frequent injections typically required by anti-VEGF treatments. Currently undergoing clinical trials, ABBV-RGX-314 has the potential to improve disease management and patient experience through sustained therapeutic effects.
Retina Futura is thrilled to celebrate this year’s winners, whose innovative work exemplifies the dedication and creativity driving progress in retinal therapies. We are proud to share their accomplishments with the global ophthalmology community and look forward to seeing how these advancements will continue to inspire breakthroughs in patient care.
About Retina Futura Awards
The Retina Futura Awards are an annual celebration of excellence in retinal disease research and treatment. These awards inspire progress in ophthalmology by honoring trailblazing scientists and clinicians. Winners are selected by an esteemed panel of experts during the Retina Futura Congress, attended by leaders in the field from across the globe.
About RetinaFUTURA
RetinaFUTURA is dedicated to uniting retina specialists, researchers, and industry innovators to advance clinical knowledge and therapies for retinal diseases. The platform fosters collaboration among professionals, offering a forum to share cutting-edge research, debate the safety and efficacy of emerging treatments, and promote real-world studies. RetinaFUTURA’s mission is to improve patient care and celebrate the passion that drives advancements in ophthalmology.